Anti-cancer pharmaceutical composition, preparation method thereof, oral liquid and preparation method of oral liquid
A composition and oral liquid technology, applied in the field of rare earth element pharmaceutical composition, can solve problems such as unreported results, achieve the effect of improving immunity, quick effect, and improving the ability of anti-cancer and inhibiting cancer cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] A kind of raw material ratio of improving immunity and anticancer pharmaceutical composition is as shown in table 1, and the chemical group C of calcium citrate 6 h 8 o 7 .3 / 2Ga.2H 2 O:
[0050] Table 1
[0051]
[0052]
[0053] The above 1-1, 1-2 and 1-3 are used as the control group, in which lanthanum oxide and cerium oxide are not added at the same time, as the control group. The amount of lanthanum oxide added in 1-4, 1-5, and 1-6 is greater than that of cerium oxide, and the amount of cerium oxide added in 1-7, 1-8, 1-9, 1-10, and 1-11 is greater than that of cerium oxide The amount of lanthanum oxide added.
[0054] Rat liver cancer cells were raised with the pharmaceutical composition in Table 1 for 90 days, one course of treatment every 25 days, with an interval of 5 days, and 6 mg of the pharmaceutical composition corresponding to the above-mentioned group numbers was injected every day during the treatment period, and its performance index after 9...
Embodiment 2
[0064] The raw material ratio of a pharmaceutical composition that improves immunity and fights cancer is shown in Table 3:
[0065] Form 3
[0066] Group No Lanthanum oxide / mg Cerium oxide / mg Praseodymium oxide / mg NdO / mg Citric acid / mg Calcium citrate / mg 2-1 70.0 29.91 0.03 0.06 0 0 2-2 70.0 17.91 0.03 0.06 6 6 2-3 60.0 39.91 0.03 0.06 0 0 2-4 60.0 26.91 0.03 0.06 6.5 6.5 2-5 50.0 49.91 0.03 0.06 0 0 2-6 50.0 36.91 0.03 0.06 7 6 2-7 45.0 54.91 0.03 0.06 0 0 2-8 45.0 41.91 0.03 0.06 8 5 2-9 40.0 59.91 0.03 0.06 0 0 2-10 40.0 46.91 0.03 0.06 8 5
[0067] The difference between 2-1 and 2-2 is enough to add citric acid and calcium citrate. 2-3 and 2-4 are the same analogy. Rat liver cancer cells were raised with the pharmaceutical composition in Table 3 for 90 days, with a course of treatment every 25 days, with an interval of 5 days. During the treatment ...
Embodiment 3
[0073] A kind of raw material proportioning of the medicinal composition of improving immunity and anticancer is shown in Table 5:
[0074] Form 5
[0075] Group No Lanthanum oxide / mg Cerium oxide / mg Praseodymium oxide / mg NdO / mg Citric acid / mg Calcium citrate / mg 3-1 48.0 61.09 0.027 0.063 8 5 3-2 46.5 40.41 0.028 0.062 8 5 3-3 44.5 42.41 0.029 0.061 8 5 3-4 43.0 43.91 0.035 0.055 8 5 3-5 41.5 45.41 0.034 0.056 8 5 3-6 40.0 46.91 0.033 0.057 8 5 3-7 38.5 48.41 0.032 0.058 8 5 3-8 37.8 49.11 0.03 0.06 8 5 3-9 36.2 50.715 0.029 0.056 8 5 3-10 35.0 51.91 0.035 0.055 8 5 3-11 34.5 65.41 0.036 0.054 8 5
[0076] Rat liver cancer cells were raised with the pharmaceutical composition in Table 5 for 90 days, with a course of treatment every 25 days, with an interval of 5 days. During the treatment period, 6 mg of the pharmaceutical composition correspond...
PUM
Property | Measurement | Unit |
---|---|---|
sedimentation rate | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com